1-6 of 6
Soo Min Lim
Close
Sort by
Journal Articles

Efficacy and Safety of Luspatercept in Patients with HbE/β-Thalassemia from the BELIEVE Study: A Subgroup Analysis

Kevin H.M. Kuo, Pranee Sutcharitchan, Ping Chong Bee, Lee Ping Chew, Soo Min Lim, Ai Sim Goh, Sadanand Vodala, Wen-Ling Kuo, Yinzhi Lai, Loyse Felber Medlin, Martina Perin, Luciana Moro Bueno, Thomas D Coates, Vip Viprakasit
Journal: Blood
Blood (2023) 142 (Supplement 1): 3848.
https://doi.org/10.1182/blood-2023-174082
Published: 2023
Journal Articles

Efficacy of SB12 (Eculizumab Biosimilar) in Asian and Non-Asian Patients with Paroxysmal Nocturnal Hemoglobinuria: Subgroup Analysis of a Global Phase III Randomized Controlled Trial

Jun Ho Jang, Soo Min Lim, Ciprian Tomuleasa, Hanna Oliynyk, Theerin Lanamtieng, Jihye Park, Younsoo Kim, Jinah Jung, Paola Russo
Journal: Blood
Blood (2023) 142 (Supplement 1): 2727.
https://doi.org/10.1182/blood-2023-191275
Published: 2023
Journal Articles

A Real-World Study to End Tyrosine Kinase Inhibitor in Chronic Myeloid Leukaemia (EnTIC) in Malaysia: One Year Follow-up of Multicenter Study in Malaysia

SiewLian Chong, Tee Chuan Ong, Wirda Asnawi, Tien Gen Wong, Mohamed Ahmad Zakiyy, Yea Bing Tham, Nur Aini Syakirah Ahmad Shuyuti, Sharifah Shahnaz Binti Syed Abd Kadir, Jerome Tan, Kim Wah Ho, Ngee Siang Lau, Yap Yee Yee, Veena Selvaratnam, Sen Mui Tan, Ai Sim Goh, Ching Soon Teoh, Sui Keat, Soo Min Lim, Azizan Sharif, Yang Liang Boo, Christopher Liam, Ahlam Naila Kori, See Guan Toh, Ee Leng Gan, Si Yuan Ng, Siong Leng Hon, Jenq Tzong Tan
Journal: Blood
Blood (2022) 140 (Supplement 1): 12213–12214.
https://doi.org/10.1182/blood-2022-169104
Published: 2022
Journal Articles

Sensitivity Analysis on the Primary Efficacy Results of SB12 (Eculizumab Biosimilar) Phase III Study in Paroxysmal Nocturnal Hemoglobinuria Patients

Jun Ho Jang, Roberta Demichelis, Larysa Nogaieva, Lily LL Wong, Soo Min Lim, Younsoo Kim, Jihye Park
Journal: Blood
Blood (2022) 140 (Supplement 1): 8658–8659.
https://doi.org/10.1182/blood-2022-158387
Published: 2022
Journal Articles

Chronic Myeloid Leukemia Failed Second Generation Tyrosine Kinase Inhibitor Patients' Molecular Interrogation Using Next Generation Sequencing

SiewLian Chong, Yang Liang Boo, Wirda Asnawi, Pek Kuen Liew, Tee Chuan Ong, Veena Selvaratnam, Sharifah Shahnaz Syed Abd Kadir, Jerome Tan, KIM Wah HO, Yih Seong Seong Wong, Soo Min Lim, Subramanian Yegappan, Sen Mui Tan
Journal: Blood
Blood (2022) 140 (Supplement 1): 11544–11545.
https://doi.org/10.1182/blood-2022-162155
Published: 2022
Journal Articles

The Believe Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia Patients Who Require Regular Red Blood Cell (RBC) Transfusions

Maria Domenica Cappellini, MD, Vip Viprakasit, MD DPhil, Ali Taher, MDPhD, Pencho Georgiev, MD, Kevin H. M. Kuo, MDMSc,FRCPC, Thomas D. Coates, MD, Ersi Voskaridou, MD, Hong Keng Liew, Idit Pazgal-Kobrowski, Gianluca Forni, Silverio Perrotta, Abderrahim Khelif, Ashutosh Lal, MD, Antonis Kattamis, Efthymia Vlachaki, Raffaella Origa, MD, Yesim Aydinok, Mohamed Bejaoui, P. Joy Ho, Lee Ping Chew, Ping Chong Bee, Soo Min Lim, Meng-Yao Lu, Adisak Tantiworawit, Penka Ganeva, Liana Gercheva, Farrukh Shah, Ellis J. Neufeld, Abderrahmane Laadem, MD, Jeevan K. Shetty, Jun Zou, MDPhD, Dimana Miteva, PhD, Tatiana Zinger, PhD, Peter G. Linde, Matthew L. Sherman, Olivier Hermine, MDPhD, John Porter, MA MDFRCP FRCPath, Antonio Piga
Journal: Blood
Blood (2018) 132 (Supplement 1): 163.
https://doi.org/10.1182/blood-2018-163
Published: 2018